The Pap test: George N. Papanicolaou (1883-1962. )A screening test for the prevention of cancer of uterine cervix

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 90, Issue 2, 2000, Pages 135-138

  Michalas, Stylianos P ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; FEMALE; HISTORY OF MEDICINE; HUMAN; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCREENING TEST; SHORT SURVEY; UTERINE CERVIX CANCER; WART VIRUS;

EID: 0034124613     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(00)00260-8     Document Type: Review

References (28)

1. Stack P.S. Pap smears. Still a reliable screening tool for cervical cancer. Postgrad. Med. 101:1997;207-208.
2. Papanicolaou G.N., Traut H.F. The diagnostic value of vaginal smears in carcinoma of the uterus. Am. J. Obstet. Gynecol. 42:1941;193-206.
3. Di Saia P.J., Creasman W.C. Clinical gynecologic oncology. 1989;C.V. Mosby, St. Louis.
4. Hinsey J.C. George Nicholas Papanicolaou M.D., PhD, DSc, May 13, 1883-February 19, 1962. Acta Cytol. 6:1962;483-486.
5. Barter J.F. The life and contributions of Doctor George Nicholas Papanicolaou. Surg. Gynecol. Obstet. 174:1992;530-532.
6. Grunze H, Spriggs AI. History of clinical cytology - a selection of documents. G-I-T Verlag-Ernst Giebeler, 85-92.
7. De May R.M. Common problems in Papanicolaou smear interpretation. Arch. Pathol. Lab. Med. 121:1997;229-238.
8. Boronow R.C. Death of the Papanicolaou smear? A tale of three reasons. Am. J. Obstet. Gynecol. 179:1998;391-396.
9. Kinney W.K., Manos M.M., Hurley L.B., et al. Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses. Obstet. Gynecol. 91:1998;973-976.
10. Foulks M.J. The Papanicolaou smear; its impact on the promotion of women's health. J. Obstet. Gynecol. Neonatal Nurs. 27:1998;367-373.
11. Lee K.R., Ash Fag R., Birdsong G.G., et al. Comparison of conventional Papanicolaou smears and a fluid-based, thin-layer system for cervical cancer screening. Obstet. Gynecol. 90:1997;278-284.
12. Bollic D.R., Hellman D.J. Laboratory implementation and efficacy assessment of the Thin Prep cervical cancer screening system. Acta Cytol. 42:1998;209-213.
13. Bishop J.W., Bigner S.H., Colgan T.J., et al. Multicenter masked evaluation of AutoCyte PREP thin layers with matched conventional smears. Including initial biopsy results. Acta Cytol. 42:1998;189-197.
14. Spenger E., Schwarzmann P., Kirkparvick M., et al. The false negative rate in cervical cytology. Comparison of monolayers to conventional smears. Acta Cytol. 40:1996;81-91.
15. Sherman M.E., Schiffman M.H., Lorincz A.T., et al. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirous testing. Cancer. 81:1997;89-97.
16. Rosenthal D.L., Acosta D., Peters R.K. Computer-assisted rescreening of clinically important false negative cervical smears using the PAPNET Testing System. Acta Cytol. 40:1996;120-126.
17. Koss L.G., Sherman M.E., Cohen M.B., et al. Significant reduction in the rate of false negative cervical smears with neural network-based technology (PAPNET Testing System). Hum. Pathol. 28:1997;1196-1203.
18. Assessment of automated primary screening on PAPNET of cervical smears in the Prismatic trial. Lancet. 353:1999;1381-1385.
19. Shulman L.P., Klett C.C., Phillips O.P. Preliminary comparison of Papanicolaou smear and speculoscopy for assessing cervical cancer precursor lesions in pregnant adolescents. J. Pediatr. Adolesc. Gynecol. 12:1999;78-82.
20. van Niekerk W.A., Dunton C.J., Richart R.M., et al. Colposcopy, cervicography, speculoscopy and endoscopy. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial. Acta Cytol. 42:1998;33-49.
21. Burghardt E. Colposcopy-cervical pathology. Textbook and atlas. 1991;30-32 Thieme Medical Publishers, New York.
22. Puranen M., Saarikoski S., Surjanen K., et al. Polymerase chain reaction amplification of human papillomavirus DNA from archival, Papanicolaou-stained cervical smears. Acta Cytol. 40:1996;391-395.
23. Lorinez A.T. Hybrid capture methods for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening. J. Obstet. Gynecol. Res. 22:1996;629-636.
24. Cope J.U., Hildeshein A., Schiffman M.H., et al. Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens. J. Clin. Microbiol. 35:1997;2262-2265.
25. McGoogan E., Seagar A.L., Cubie H.A. Detection of high-risk human papillomavirus nucleic acid in archival cervical smears. Acta Cytol. 42:1998;1079-1083.
26. Autillo-Touati A., Johannes M., d' Eccole C., et al. HPV typing by in situ hybridization on cervical cytologic smears with ASCUS. Acta Cytol. 42:1998;631-638.
27. Vassilakos P., de Marval F., Munoz M., et al. Human papillomavirus (HPV) DNA assay as an adjunct to liquid-based Pap testing the diagnostic triage of women with an abnormal Pap smear. Int. J. Gynecol. Obstet. 61:1998;45-50.
28. Vilos G.A. The history of the Papanicolaou smear and the odyssey of George and Andromache Papanicolaou. Obstet. Gynecol. 91:1998;479-483.